Mar 05, 2012, 10.28 AM | Source: Reuters
Cipla said it had received government notices seeking Rs 425 crore due to over pricing of certain drugs.
The demands are contrary to the orders passed by the Supreme Court of India and are related to the same drugs under litigation, the drugmaker said in a statement.
The company has received a legal advice which says the entire amount demanded by the National Pharmaceutical Pricing Authority (NPPA) is not tenable and sustainable, Cipla said.
NPPA is a government body that fines drugmakers in India if they over price certain drugs that have been identified under the national list of essential medicines.
In a regulatory filing, Cipla said the Supreme Cou
Sales are expected to increase by 18.7 percent Q-o
Net Sales are expected to increase by 21.7 percent
"...proposed biotech subsidiary in South Africa wi
Drug firm Cipla will invest around Rand 1.3 billio